We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cryopreserved Umbilical Cord Aids Fetal Spina Bifida Repair

By HospiMedica International staff writers
Posted on 25 Jul 2016
A patch made from cryopreserved human umbilical cord could promote myeloschisis defect (spina bifida) repair in the womb, according to a new study.

The study, by researchers at the University of Texas Health Science Center (UTH; Houston, USA), Memorial Hermann Health System (Houston, TX, USA), and TissueTech (Doral, FL, USA), who developed the patch, presents two cases of large myeloschisis defects that underwent in utero spina bifida repair at midgestation, using the human umbilical cord patch for closure of the skin defect. More...
When the newborns were delivered at 37 week by planned cesarean delivery, the researchers found that the repair sites were intact, with no evidence of cerebrospinal fluid leakage.

Short-term outcomes after delivery showed reversal of hindbrain herniation, minimal spinal cord tethering, and normal function of the lower extremities. The skin also regenerated after patch delivery within a period of 3-4 weeks. In both cases the child had normal movements of the lower extremities and bladder control function, and the Chiari II malformation was completely reversed. The study was published on July 7, 2016, in Obstetrics & Gynecology.

“The promise of this patch is that the umbilical cord contains specific natural material called heavy chain hyaluronic acid/pentraxin3 that has regenerative properties,” said lead author Ramesha Papanna, MD, MPH. “It allows the local tissue to grow in at the repair site instead of a healing by scar formation that occurs with traditional repair methods. This decrease in scar formation may help improve the spinal cord function further and reduce the need for future surgeries to remove the effects of the scar tissue on the spinal cord.”

“The use of this patch for fetal repair heralds a new era for fetal spina bifida repair,” said study co-author Professor Kenneth Moise, MD, co-director of UTH The Fetal Center. “For the first time, a bioscaffold has been successfully employed to allow the fetus to heal itself. The implications for the future of a minimally invasive approach to fetal spina bifida repair and even neonatal spina bifida repair are enormous.”

Spina bifida is a developmental congenital disorder caused by the incomplete closing of the embryonic neural tube; if the opening is large enough, a portion of the spinal cord can protrude through; the most common location is the lumbar and sacral areas. Myelomeningocele is the most significant form of spina bifida, and leads to disability in most affected individuals. The incidence of spina bifida can be decreased by up to 70% when daily folic acid supplements are taken prior to conception.

Related Links:
University of Texas Health Science Center
Memorial Hermann Health System
TissueTech

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.